Intelligence · Clinical Pipeline
Vertex Pharmaceuticals (Australia) Pipeline
All ClinicalTrials.gov programs at Vertex Pharmaceuticals (Australia) — phase, modality, and trial IDs.
- Programs
- 5
Quick answer
Vertex Pharmaceuticals (Australia) has 5 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
LUM/IVA
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
8 trials -
Suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Acute Pain
2 trials -
Suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Pain
6 trials -
Telaprevir
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
11 trials -
suzetrigine
Vertex Pharmaceuticals (Australia) Pty.
Pain, Acute Postoperative
1 trial
Frequently asked questions
How many pipeline programs does Vertex Pharmaceuticals (Australia) have?
5 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs